INTERFERON BETA-1A for Multiple sclerosis relapse: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where INTERFERON BETA-1A was used for Multiple sclerosis relapse.
Most Reported Side Effects for INTERFERON BETA-1A
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 5,931 | 8.8% | 45 | 3,123 |
| Influenza like illness | 4,475 | 6.6% | 12 | 861 |
| Memory impairment | 3,468 | 5.1% | 3 | 547 |
| Multiple sclerosis | 3,412 | 5.1% | 185 | 960 |
| Fatigue | 3,164 | 4.7% | 11 | 736 |
| Fall | 3,128 | 4.6% | 48 | 1,571 |
| Gait disturbance | 3,031 | 4.5% | 18 | 892 |
| Death | 2,766 | 4.1% | 2,765 | 127 |
| Pain | 2,692 | 4.0% | 19 | 677 |
| Headache | 2,533 | 3.8% | 8 | 667 |
| Drug ineffective | 2,238 | 3.3% | 19 | 449 |
| Injection site pain | 2,132 | 3.2% | 2 | 356 |
| Malaise | 2,000 | 3.0% | 24 | 510 |
| Pyrexia | 1,688 | 2.5% | 21 | 574 |
| Hypoaesthesia | 1,685 | 2.5% | 5 | 490 |
Other Indications for INTERFERON BETA-1A
Multiple sclerosis (56,475)
Product used for unknown indication (7,473)
Relapsing-remitting multiple sclerosis (2,058)
Maternal exposure timing unspecified (245)
Relapsing multiple sclerosis (192)
Secondary progressive multiple sclerosis (89)
Covid-19 (31)
Primary progressive multiple sclerosis (27)
Exposure via father (20)
Progressive multiple sclerosis (19)
Other Drugs Used for Multiple sclerosis relapse
OCRELIZUMAB (373)
FINGOLIMOD (355)
METHYLPREDNISOLONE (291)
TERIFLUNOMIDE (216)
CORTICOTROPIN (173)
OFATUMUMAB (158)
ALEMTUZUMAB (155)
GLATIRAMER (133)
OZANIMOD (84)
SIPONIMOD (70)